Crossmark

The features and prognostic value of ARID1A mutation and protein expression in endometrial cancer of no specific molecular profile (NSMP) subtype: a retrospective study in a large Chinese cohort

Crossref DOI link: https://doi.org/10.1007/s00432-026-06440-w

Published Online: 2026-03-13

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yuan, Xinhui

Cai, Mengyuan

Yu, Changmin

Zhai, Zhengyao

Zhou, Xiaoyan

Wang, Huaying

Ren, Yulan
Funding

Funding for this research was provided by:

Shanghai Science and Technology Innovation Action Plan (No. 20Z11900703)

Climb Grant of National Cancer Center (No. NCC201909B02)
License Information

Text and Data Mining valid from 2026-03-13

Version of Record valid from 2026-03-13
More Information

Article History

Received: 12 January 2026

Accepted: 12 February 2026

First Online: 13 March 2026

Declarations

:

: The authors declare no competing interests.

: This study was approved by the clinical ethics committee of Fudan University Shanghai Cancer Center, Fudan University. All patients had signed informed consent. This study was in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration.

: Not applicable.

Document is current

Any future updates will be listed below